1578-57-0

Basic information

• Product Name: 2-fluorohexanoic acid
• Synonyms: Hexanoic acid, 2-fluoro-
• CAS NO: 1578-57-0
• Molecular Formula: C₆H₁₁FO₂
• Molecular Weight: 134.1487
• Mol File: 1578-57-0.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 209.5°C at 760 mmHg
• Flash Point: 80.5°C
• Density: 1.047g/cm³
• Vapor Pressure: 0.0804mmHg at 25°C
• Refractive Index: 1.407
• CAS DataBase Reference: 2-fluorohexanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-fluorohexanoic acid(1578-57-0)
• EPA Substance Registry System: 2-fluorohexanoic acid(1578-57-0)

Safety Data

• Hazardous Substances Data: 1578-57-0(Hazardous Substances Data)

Upstream product

• 17841-31-5 2-fluoro hexane-1-oate d'ethyle 
• 1578-77-4 diethyl 2-butyl-2-fluoromalonate 
• 615-96-3 Ethyl 2-bromohexanoate 
• 108200-51-7 monofluoroketene hemithioacetal 
• 108200-51-7 1-Methoxy-1-(phenylthio)-2-fluoro-1-hexene 
• 70387-20-1 1,1-bis-ethylsulfanyl-2-fluoro-hex-1-ene 

Downstream Products

• 108545-24-0 (S)-N-((R)-α-hydroxymethylbenzyl)-2-fluoro-2-methylhexanamide 
• 108545-23-9 (R)-N-((R)-α-hydroxymethylbenzyl)-2-fluoro-2-methylhexanamide 
• 936111-26-1 C₃₅H₄₅FO₅SSi 
• 26450-58-8 1,1-dimethoxy-pentane 
• 936111-34-1 C₃₆H₄₇FO₄SSi 

Relevant articles and documents

Electrolytic Reactions of Fluoro Organic Compounds. 7. Anodic Methoxylation and Acetoxylation of 2,2,2-Trifluoroethyl Sulfides. Preparation of Highly Useful Trifluoromethylated Building Blocks

Anodic methoxylation and acetoxylation of 2,2,2-trifluoroethyl sulfides and the corresponding nonfluorinated sulfides were comparatively studied.It was found that a trifluoromethyl group remarkably promoted anodic substitution and methoxy and acetoxy groups were introduced adjacent to the trifluoromethyl group of the sulfides.Longer perfluoroalkyl groups also promoted these anodic substitutions.These products were shown to be highly useful building blocks fro the synthesis of fluoro organic compounds.

16-Substituted prostaglandins

A process for producing optically active 16-substituted prostaglandins and new 16-substituted prostaglandins produced thereby which are useful as cardiovascular agents and as agents for inducing labor in pregnant females and for the termination of pregnancy.

13,14-Dihydro-16-fluoro prostaglandin F1

Prostaglandin-type compounds with one or two fluoro substituents at the C-16 position are disclosed, with processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, labor inducement at term, and wound healing.